Sensitivity and specificity of in vitro diagnostic device used for influenza rapid test in Taiwan |
| |
Authors: | Kun-Teng Wang Chia-Pei Lin Yi-Ya Fang Ming-Hui Kao Daniel Yang-Chih Shih Chi-Fang Lo Der-Yuan Wang |
| |
Affiliation: | 1. Section of Biologics, Division of Research and Analysis, Food and Drug Administration, Ministry of Health and Welfare, Taiwan, ROC;2. Division of Research and Analysis, Food and Drug Administration, Ministry of Health and Welfare, Taiwan, ROC;3. Food and Drug Administration, Ministry of Health and Welfare, Taiwan, ROC |
| |
Abstract: | The pandemic influenza A/H1N1 outbreak resulted in 18,449 deaths in over 214 countries. In Taiwan, the influenza rapid test, an in vitro diagnostic device (Flu-IVD), only requires documented reviews for market approval by the Taiwan Food and Drug Administration. The purpose of this study was to investigate the analytical sensitivity and specificity of Flu-IVDs used in Taiwan. Analytical sensitivity and specificity tests were performed for influenza antigens A/California/7/2009 (H1N1) virus, A/Victoria/210/2009 (H3N2) virus, B/Brisbane/60/08 virus, and human coronavirus OC43. A total of seven domestic and 31 imported Flu-IVD samples were collected, of which, 20 samples had inadequate labeling, including those with removed package inserts or incorrect insert information. The analytical sensitivity of Flu-IVDs for A/H1N1, A/H3N2, and Flu B was 500–1000 ng/mL, 1000 ng/mL, and 1000 ng/mL, respectively. For the 50% cell culture infective dose (CCID50) label, the average A/H1N1 and A/H3N2 sensitivity for Flu-IVDs was log10 5.8 ± 0.5 and log10 6.6 ± 0.5 CCID50/mL, respectively. As to the specificity test, no product cross-reacted with human coronavirus OC43. This study provides important information on the Flu-IVD regulation status and can thus help the government formulate policies for the regulation of in vitro diagnostic devices in Taiwan. |
| |
Keywords: | Pandemic influenza A (H1N1) virus Sensitivity Specificity |
本文献已被 ScienceDirect 等数据库收录! |
|